RARG and cardiomyopathy: Despite that replication studies of the association of the RARG variant with cardiotoxicity were inconsistent, a functional study in iPSC-derived cardiomyocytes showed that the variant RARG increases sensitivity to doxorubicin-induced cardiomyopathy [98].